Abstract
2-O-carboxymethylpyrogallol derivatives (4-17) were synthesized, with their in vitro inhibitory activities against PTP1B and in vivo antihyperglycemic effects examined. Compound 14, the most potent among the series, showed a K(i) value of 1.1 microM against PTP1B, 7-fold lower than that against TC-PTP. When compound 14 was fed to a high-fat diet-induced diabetic mouse model, significant improvements were observed in both the fasting glucose level and glucose tolerance.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Blood Glucose / metabolism
-
Cell Membrane Permeability / drug effects
-
Diabetes Mellitus, Type 2 / drug therapy
-
Dietary Fats
-
Glucose Tolerance Test
-
Hyperglycemia / drug therapy*
-
Hypoglycemic Agents / chemical synthesis*
-
Hypoglycemic Agents / pharmacology*
-
Insulin Resistance
-
Kinetics
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Protein Tyrosine Phosphatases / antagonists & inhibitors
-
Structure-Activity Relationship
Substances
-
Blood Glucose
-
Dietary Fats
-
Hypoglycemic Agents
-
Protein Tyrosine Phosphatases